Cryptojaponol

Cryptojaponol

SCHEMBL13532267

COc1c(C(C)C)cc2c(c1O)[C@@]1(C)CCCC(C)(C)[C@@H]1CC2=O

nearest known ligand 0.60

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 10/20 0.60
▸ GGPS1 O95749 6/20 0.60
▸ TSHR P16473 1/20 0.42
▸ ALDH1A1 P00352 3/20 0.41
▸ CYP3A4 P08684 3/20 0.41
▸ MAPT P10636 3/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ PTGES O14684 2/20 0.41
▸ PNLIP P16233 2/20 0.41
▸ MEN1 O00255 2/20 0.41
▸ KMT2A Q03164 2/20 0.41
▸ CYP19A1 P11511 1/20 0.39
▸ BCL9 O00512 3/20 0.39
▸ CTNNB1 P35222 3/20 0.39
▸ HPGD P15428 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ ALOX12 P18054 1/20 0.39
▸ GSTO1 P78417 1/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ USP2 O75604 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cryptojaponol SCHEMBL30600453 1.00 FDPS (0.60) FDPSGGPS1TSHRALDH1A1CYP3A4
Cryptojaponol SCHEMBL18290238 1.00 FDPS (0.60) FDPSGGPS1TSHRALDH1A1CYP3A4
Demethylcryptojaponol SCHEMBL13532270 0.89 FDPS (0.67) FDPSGGPS1ALDH1A1CYP3A4MAPT
Demethylcryptojaponol SCHEMBL28596866 0.89 FDPS (0.67) FDPSGGPS1ALDH1A1CYP3A4MAPT
Demethylcryptojaponol SCHEMBL16006713 0.89 FDPS (0.67) FDPSGGPS1ALDH1A1CYP3A4MAPT
SCHEMBL13533287 0.88 FDPS (0.54) FDPSGGPS1TSHRALDH1A1CYP3A4
SCHEMBL18290241 0.77 CYP19A1 (0.60) FDPSGGPS1ALDH1A1CYP3A4MAPT
Sugiol SCHEMBL17407685 0.76 SOD1 (0.58) FDPSGGPS1ALDH1A1CYP3A4MAPT
Sugiol SCHEMBL28605319 0.76 SOD1 (0.58) FDPSGGPS1ALDH1A1CYP3A4MAPT
Sugiol SCHEMBL1086916 0.76 SOD1 (0.58) FDPSGGPS1ALDH1A1CYP3A4MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8519007-B2 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases ACADEMIA SINICA (TW) 2013-08-27 — — US disclosed
US-8519007-B2 Use certain diterpene compounds in the treatment of androgen receptor-associated diseases ACADEMIA SINICA (TW) 2013-08-27 — — US disclosed
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES ACADEMIA SINICA (TW) 2010-01-28 — — US disclosed
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES ACADEMIA SINICA (TW) 2010-01-28 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100022632-A1 USE CERTAIN DITERPENE COMPOUNDS IN THE TREATMENT OF ANDROGEN RECEPTOR-ASSOCIATED DISEASES AR, CYP17A1, CYP19A1 FDPS 178/4885GGPS1 368/4885TSHR 1293/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback